The first text to offer complete, diagnosis-centered guidance on the effective use of emerging PET technology, Specialty Imaging: PET is a one-stop resource, expertly tailored to your decision support needs at the point of care. This accessible reference covers everything you need to know about the key role of PET in the complex field of precision medicine in areas including oncology, cardiac, infection and inflammation, vascular, breast, neurological, musculoskeletal, gastrointestinal, neuroendocrine, and many other specialties. With a practical, clinically oriented focus, it brings you fully up-to-date with research-based information on PET and how PET has resulted in radically new treatment approaches based on an immediate and molecular response to therapy.
1. INTRODUCTION - p. xiii 2. Chapter 1: Overview - p. xiii 3. INTERPRETATION - p. 7 4. Chapter 2: Approach to Interpretation - p. 7 5. Chapter 3: Artifacts and Pitfalls - p. 13 6. PROTOCOLS - p. 19 7. Chapter 4: Whole-Body PET/CT Protocols - p. 19 8. PHYSICS AND RADIOPHARMACEUTICALS - p. 23 9. RADIOPHARMACEUTICALS - p. 23 10. Chapter 5: Clinical Radiopharmaceuticals - p. 23 11. Chapter 6: Radiopharmaceuticals in Development - p. 29 12. Chapter 7: Radiopharmaceutical Production - p. 31 13. PHYSICS AND QUALITY CONTROL - p. 33 14. Chapter 8: Positron Emission Tomography - p. 33 15. Chapter 9: Nonimaging Detectors - p. 41 16. Chapter 10: Radiation Biology and Dose - p. 43 17. SECTION 2: ONCOLOGY - p. 47 18. ADRENAL ONCOLOGY - p. 47 19. Chapter 11: Adrenocortical Carcinoma - p. 47 20. BREAST ONCOLOGY - p. 53 21. Chapter 12: Primary Breast Cancer - p. 53 22. Chapter 13: Breast Cancer Staging - p. 59 23. CENTRAL NERVOUS SYSTEM ONCOLOGY - p. 65 24. Chapter 14: Brain Metastases - p. 65 25. Chapter 15: Postradiation Evaluation - p. 73 26. Chapter 16: Primary Brain Malignancy - p. 79 27. CUTANEOUS ONCOLOGY - p. 83 28. Chapter 17: Melanoma - p. 83 29. Chapter 18: Merkel Cell Carcinoma - p. 89 30. GASTROINTESTINAL ONCOLOGY - p. 93 31. Chapter 19: Esophageal Cancer - p. 93 32. Chapter 20: Gastric Cancer and Gastrointestinal Stromal Tumor - p. 99 33. Chapter 21: Anal Carcinoma - p. 103 34. Chapter 22: Colorectal Carcinoma - p. 107 35. Chapter 23: Peritoneal Carcinomatosis and Mesothelioma - p. 111 36. GENITOURINARY ONCOLOGY - p. 115 37. Chapter 24: Uterine and Endometrial Cancers - p. 115 38. Chapter 25: Ovarian Cancer - p. 121 39. Chapter 26: Cervical Cancer - p. 125 40. Chapter 27: Vulvar and Vaginal Cancer - p. 131 41. Chapter 28: Prostate Cancer - p. 137 42. Chapter 29: Testicular Cancer - p. 147 43. Chapter 30: Renal Cell Carcinoma - p. 153 44. Chapter 31: Transitional Cell Carcinoma - p. 157 45. HEAD AND NECK CANCER - p. 161 46. Chapter 32: Squamous Cell Carcinoma - p. 161 47. Chapter 33: Parotid and Salivary Gland Carcinoma - p. 167 48. HEPATOBILIARY ONCOLOGY - p. 171 49. Chapter 34: Biliary Malignancy - p. 171 50. Chapter 35: Hepatocellular Carcinoma - p. 177 51. PANCREATIC ONCOLOGY - p. 181 52. Chapter 36: Pancreatic Adenocarcinoma - p. 181 53. THORACIC ONCOLOGY - p. 185 54. Chapter 37: Pulmonary Carcinoid Tumor - p. 185 55. Chapter 38: Non-Small Cell Lung Cancer - p. 189 56. Chapter 39: Malignant Pleural Mesothelioma - p. 195 57. Chapter 40: Small Cell Lung Cancer - p. 199 58. Chapter 41: Solitary Pulmonary Nodule - p. 201 59. Chapter 42: Thymoma and Thymic Carcinoma - p. 207 60. THYROID AND PARATHYROID CARCINOMA - p. 211 61. Chapter 43: Anaplastic Thyroid Carcinoma - p. 211 62. Chapter 44: Papillary and Follicular Thyroid Cancer - p. 213 63. Chapter 45: Medullary Thyroid Carcinoma - p. 217 64. LYMPHOMA - p. 221 65. Chapter 46: Hodgkin Lymphoma - p. 221 66. Chapter 47: Non-Hodgkin Lymphoma - p. 227 67. MUSCULOSKELETAL ONCOLOGY - p. 231 68. Chapter 48: Multiple Myeloma - p. 231 69. Chapter 49: Sarcomas - p. 235 70. Chapter 50: Carcinoma of Unknown Primary - p. 241 71. Chapter 51: Chondrosarcoma - p. 255 72. Chapter 52: Bone Metastases - p. 257 73. NEUROENDOCRINE ONCOLOGY - p. 263 74. Chapter 53: Abdominal Carcinoid Tumors - p. 263 75. Chapter 54: Paraganglioma and Pheochromocytoma - p. 269 76. SECTION 3: PEDIATRICS - p. 273 77. Chapter 55: Pediatric Nonaccidental Trauma - p. 273 78. Chapter 56: Neuroblastoma - p. 279 79. Chapter 57: Ewing Sarcoma - p. 285 80. Chapter 58: Osteosarcoma - p. 291 81. Chapter 59: Pediatric Lymphoma - p. 297 82. SECTION 4: SOFT TISSUE INFECTION AND INFLAMMATION - p. 303 83. Chapter 60: Abdominal Infection and Inflammatory Disease - p. 303 84. Chapter 61: Granulomatous Disease - p. 307 85. Chapter 62: Fever of Unknown Origin - p. 311 86. SECTION 5: CENTRAL NERVOUS SYSTEM - p. 313 87. DEMENTIA - p. 313 88. Chapter 63: Alzheimer Disease - p. 313 89. Chapter 64: Frontotemporal Dementia - p. 321 90. Chapter 65: Lewy Body Dementia - p. 325 91. Chapter 66: Multi-Infarct Dementia - p. 329 92. EPILEPSY - p. 333 93. Chapter 67: Intractable Seizure Disorder - p. 333 94. INFECTION AND INFLAMMATION - p. 337 95. Chapter 68: Cerebral Abscess and Encephalitis - p. 337 96. SECTION 6: CARDIAC AND VASCULAR - p. 339 97. Chapter 69: Myocardial Ischemia - p. 339 98. Chapter 70: Myocardial Viability - p. 345 99. Chapter 71: Cardiac Inflammation and Infection - p. 349 100. Chapter 72: Vascular Infection and Inflammation - p. 353 101. Chapter 73: Large Vessel Vasculitis - p. 359 102. INDEX - p. 363
No hay muestra disponible
No hay ficha técnica disponible
The first text to offer complete, diagnosis-centered guidance on the effective use of emerging PET technology, Specialty Imaging: PET is a one-stop resource, expertly tailored to your decision support needs at the point of care. This accessible reference covers everything you need to know about the key role of PET in the complex field of precision medicine in areas including oncology, cardiac, infection and inflammation, vascular, breast, neurological, musculoskeletal, gastrointestinal, neuroendocrine, and many other specialties. With a practical, clinically oriented focus, it brings you fully up-to-date with research-based information on PET and how PET has resulted in radically new treatment approaches based on an immediate and molecular response to therapy.
1. INTRODUCTION - p. xiii 2. Chapter 1: Overview - p. xiii 3. INTERPRETATION - p. 7 4. Chapter 2: Approach to Interpretation - p. 7 5. Chapter 3: Artifacts and Pitfalls - p. 13 6. PROTOCOLS - p. 19 7. Chapter 4: Whole-Body PET/CT Protocols - p. 19 8. PHYSICS AND RADIOPHARMACEUTICALS - p. 23 9. RADIOPHARMACEUTICALS - p. 23 10. Chapter 5: Clinical Radiopharmaceuticals - p. 23 11. Chapter 6: Radiopharmaceuticals in Development - p. 29 12. Chapter 7: Radiopharmaceutical Production - p. 31 13. PHYSICS AND QUALITY CONTROL - p. 33 14. Chapter 8: Positron Emission Tomography - p. 33 15. Chapter 9: Nonimaging Detectors - p. 41 16. Chapter 10: Radiation Biology and Dose - p. 43 17. SECTION 2: ONCOLOGY - p. 47 18. ADRENAL ONCOLOGY - p. 47 19. Chapter 11: Adrenocortical Carcinoma - p. 47 20. BREAST ONCOLOGY - p. 53 21. Chapter 12: Primary Breast Cancer - p. 53 22. Chapter 13: Breast Cancer Staging - p. 59 23. CENTRAL NERVOUS SYSTEM ONCOLOGY - p. 65 24. Chapter 14: Brain Metastases - p. 65 25. Chapter 15: Postradiation Evaluation - p. 73 26. Chapter 16: Primary Brain Malignancy - p. 79 27. CUTANEOUS ONCOLOGY - p. 83 28. Chapter 17: Melanoma - p. 83 29. Chapter 18: Merkel Cell Carcinoma - p. 89 30. GASTROINTESTINAL ONCOLOGY - p. 93 31. Chapter 19: Esophageal Cancer - p. 93 32. Chapter 20: Gastric Cancer and Gastrointestinal Stromal Tumor - p. 99 33. Chapter 21: Anal Carcinoma - p. 103 34. Chapter 22: Colorectal Carcinoma - p. 107 35. Chapter 23: Peritoneal Carcinomatosis and Mesothelioma - p. 111 36. GENITOURINARY ONCOLOGY - p. 115 37. Chapter 24: Uterine and Endometrial Cancers - p. 115 38. Chapter 25: Ovarian Cancer - p. 121 39. Chapter 26: Cervical Cancer - p. 125 40. Chapter 27: Vulvar and Vaginal Cancer - p. 131 41. Chapter 28: Prostate Cancer - p. 137 42. Chapter 29: Testicular Cancer - p. 147 43. Chapter 30: Renal Cell Carcinoma - p. 153 44. Chapter 31: Transitional Cell Carcinoma - p. 157 45. HEAD AND NECK CANCER - p. 161 46. Chapter 32: Squamous Cell Carcinoma - p. 161 47. Chapter 33: Parotid and Salivary Gland Carcinoma - p. 167 48. HEPATOBILIARY ONCOLOGY - p. 171 49. Chapter 34: Biliary Malignancy - p. 171 50. Chapter 35: Hepatocellular Carcinoma - p. 177 51. PANCREATIC ONCOLOGY - p. 181 52. Chapter 36: Pancreatic Adenocarcinoma - p. 181 53. THORACIC ONCOLOGY - p. 185 54. Chapter 37: Pulmonary Carcinoid Tumor - p. 185 55. Chapter 38: Non-Small Cell Lung Cancer - p. 189 56. Chapter 39: Malignant Pleural Mesothelioma - p. 195 57. Chapter 40: Small Cell Lung Cancer - p. 199 58. Chapter 41: Solitary Pulmonary Nodule - p. 201 59. Chapter 42: Thymoma and Thymic Carcinoma - p. 207 60. THYROID AND PARATHYROID CARCINOMA - p. 211 61. Chapter 43: Anaplastic Thyroid Carcinoma - p. 211 62. Chapter 44: Papillary and Follicular Thyroid Cancer - p. 213 63. Chapter 45: Medullary Thyroid Carcinoma - p. 217 64. LYMPHOMA - p. 221 65. Chapter 46: Hodgkin Lymphoma - p. 221 66. Chapter 47: Non-Hodgkin Lymphoma - p. 227 67. MUSCULOSKELETAL ONCOLOGY - p. 231 68. Chapter 48: Multiple Myeloma - p. 231 69. Chapter 49: Sarcomas - p. 235 70. Chapter 50: Carcinoma of Unknown Primary - p. 241 71. Chapter 51: Chondrosarcoma - p. 255 72. Chapter 52: Bone Metastases - p. 257 73. NEUROENDOCRINE ONCOLOGY - p. 263 74. Chapter 53: Abdominal Carcinoid Tumors - p. 263 75. Chapter 54: Paraganglioma and Pheochromocytoma - p. 269 76. SECTION 3: PEDIATRICS - p. 273 77. Chapter 55: Pediatric Nonaccidental Trauma - p. 273 78. Chapter 56: Neuroblastoma - p. 279 79. Chapter 57: Ewing Sarcoma - p. 285 80. Chapter 58: Osteosarcoma - p. 291 81. Chapter 59: Pediatric Lymphoma - p. 297 82. SECTION 4: SOFT TISSUE INFECTION AND INFLAMMATION - p. 303 83. Chapter 60: Abdominal Infection and Inflammatory Disease - p. 303 84. Chapter 61: Granulomatous Disease - p. 307 85. Chapter 62: Fever of Unknown Origin - p. 311 86. SECTION 5: CENTRAL NERVOUS SYSTEM - p. 313 87. DEMENTIA - p. 313 88. Chapter 63: Alzheimer Disease - p. 313 89. Chapter 64: Frontotemporal Dementia - p. 321 90. Chapter 65: Lewy Body Dementia - p. 325 91. Chapter 66: Multi-Infarct Dementia - p. 329 92. EPILEPSY - p. 333 93. Chapter 67: Intractable Seizure Disorder - p. 333 94. INFECTION AND INFLAMMATION - p. 337 95. Chapter 68: Cerebral Abscess and Encephalitis - p. 337 96. SECTION 6: CARDIAC AND VASCULAR - p. 339 97. Chapter 69: Myocardial Ischemia - p. 339 98. Chapter 70: Myocardial Viability - p. 345 99. Chapter 71: Cardiac Inflammation and Infection - p. 349 100. Chapter 72: Vascular Infection and Inflammation - p. 353 101. Chapter 73: Large Vessel Vasculitis - p. 359 102. INDEX - p. 363
No hay muestra disponible
No hay ficha técnica disponible
